European Leukemia Trial Registry
Trial: MC-PEGASP.1/Adults

More Details
Title Randomized dose ranging trial of pegylated recombinant asparaginase
Scientific Title A randomized, multi-centre, parallel-group, open label, Oncaspar® controlled dose ranging trial of three doses of pegylated recombinant asparaginase in adult patients with newly diagnosed acute lymphoblastic leukaemia Project-No.: MC-PEGASP.1/Adults
Short Title MC-PEGASP.1/Adults
Trialgroup GMALL
Type of Trial multicentric, randomized, open-label
Disease Acute lymphoblastic leukemia(ALL) All subtypes
Age >= 18 years
Status Closed
Start of Recruitment 15.01.2011
Leader Gökbuget, Dr. med., Nicola
Contactperson

Study Physician
Gökbuget, Dr. med., Nicola
Tel: +49 (0)69 6301-6366
Fax: +49 (0)69 6301- 7463
Email: goekbuget@em.uni-frankfurt.de

Study Centre
Zahed, Akram
Tel: +49 (0)69 6301 6663
Fax: +49 (0)69 6031 7463
Email: Akram@med.uni-frankfurt.de

Centre of Trial Universitätsklinikum Frankfurt
Shortprotocol Shortprotocol
created 17.02.2011 Roswitha Kotthoff
changed 29.08.2012 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org